BassieNL schreef op 16 september 2019 11:16:
Committee for medicinal products for human use (
CHMP)
Agenda for the meeting on 16-19 September 2019
3.4.3. viable T-cells - Orphan - ATMP - EMEA/H/C/002397
Kiadis Pharma Netherlands B.V.; adjunctive treatment in haematopoietic stem cell
transplantation (HSCT) for a malignant disease
Scope: Report from ad-hoc expert group meeting held on 3 September 2019
Action: For information
List of Outstanding Issues adopted on 27.06.2019, 14.09.2018, 25.05.2018. List of Questions
adopted on 08.09.2017.
www.ema.europa.eu/en/documents/agenda...